Jill Chappell

511 total citations
13 papers, 396 citations indexed

About

Jill Chappell is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Jill Chappell has authored 13 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jill Chappell's work include Pharmacogenetics and Drug Metabolism (5 papers), Receptor Mechanisms and Signaling (3 papers) and Treatment of Major Depression (3 papers). Jill Chappell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Receptor Mechanisms and Signaling (3 papers) and Treatment of Major Depression (3 papers). Jill Chappell collaborates with scholars based in United States, Singapore and United Kingdom. Jill Chappell's co-authors include Mary Pat Knadler, Evelyn D. Lobo, Richard Bergstrom, Tonya Quinlan, Richard F. Bergstrom, Shobha Reddy, Barbara J. Ring, Corina Loghin, Mark Leibowitz and David S. Small and has published in prestigious journals such as Cancer Research, Annals of Oncology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jill Chappell

13 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Chappell United States 8 143 94 87 57 53 13 396
Elizabeth S. Duke United States 10 75 0.5× 145 1.5× 115 1.3× 42 0.7× 53 1.0× 23 666
AF Cohen Netherlands 11 99 0.7× 56 0.6× 47 0.5× 36 0.6× 52 1.0× 15 444
Kwee Poo Yeo Singapore 13 153 1.1× 131 1.4× 99 1.1× 65 1.1× 36 0.7× 26 562
C. Dubruc France 17 103 0.7× 88 0.9× 49 0.6× 98 1.7× 28 0.5× 38 670
Dwain Tolbert United States 13 153 1.1× 154 1.6× 49 0.6× 30 0.5× 86 1.6× 36 660
Richard Bergstrom United States 10 98 0.7× 159 1.7× 41 0.5× 58 1.0× 26 0.5× 16 460
Nevena Divac Serbia 13 83 0.6× 229 2.4× 47 0.5× 75 1.3× 50 0.9× 38 730
Gudrun Hefner Germany 17 127 0.9× 218 2.3× 53 0.6× 22 0.4× 19 0.4× 33 549
Aleksandra Dragičević Germany 11 178 1.2× 191 2.0× 137 1.6× 30 0.5× 33 0.6× 26 482
Shobha Reddy United States 10 214 1.5× 117 1.2× 120 1.4× 60 1.1× 50 0.9× 19 636

Countries citing papers authored by Jill Chappell

Since Specialization
Citations

This map shows the geographic impact of Jill Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Chappell more than expected).

Fields of papers citing papers by Jill Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Chappell. The network helps show where Jill Chappell may publish in the future.

Co-authorship network of co-authors of Jill Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Chappell. A scholar is included among the top collaborators of Jill Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Chappell. Jill Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhou, Lian, et al.. (2019). Elimination of [14C] LY3023414 by aldehyde oxidase and CYP enzymes in humans following oral administration. Drug Metabolism and Pharmacokinetics. 34(1). S63–S63. 2 indexed citations
2.
Perkins, E.J., et al.. (2017). Physiologically Based Pharmacokinetic Modelling of Cytochrome P450 2C9-Related Tolbutamide Drug Interactions with Sulfaphenazole and Tasisulam. European Journal of Drug Metabolism and Pharmacokinetics. 43(3). 355–367. 5 indexed citations
3.
Chappell, Jill, et al.. (2016). Abstract CT152: Food effect on the pharmacokinetics of 200-mg abemaciclib in healthy subject. Cancer Research. 76(14_Supplement). CT152–CT152. 8 indexed citations
4.
Kulanthaivel, Palaniappan, Daruka Mahadevan, P. Kellie Turner, et al.. (2016). Abstract CT153: Pharmacokinetic drug interactions between abemaciclib and CYP3A inducers and inhibitors. Cancer Research. 76(14_Supplement). CT153–CT153. 17 indexed citations
5.
Twelves, Chris, et al.. (2013). Effects of Tasisulam Sodium on the Pharmacokinetics of Tolbutamide in Patients with Advanced Solid Tumours. Annals of Oncology. 24. i33–i33. 1 indexed citations
6.
Knadler, Mary Pat, Evelyn D. Lobo, Jill Chappell, & Richard Bergstrom. (2011). Duloxetine. Clinical Pharmacokinetics. 50(5). 281–294. 179 indexed citations
7.
Chappell, Jill, et al.. (2009). Effects of Duloxetine on the Pharmacodynamics and Pharmacokinetics of Warfarin at Steady State in Healthy Subjects. The Journal of Clinical Pharmacology. 49(12). 1456–1466. 13 indexed citations
8.
Lobo, Evelyn D., Richard F. Bergstrom, Shobha Reddy, et al.. (2008). In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine. Clinical Pharmacokinetics. 47(3). 191–202. 64 indexed citations
9.
Lobo, Evelyn D., Corina Loghin, Mary Pat Knadler, et al.. (2008). Pharmacokinetics of Duloxetine in Breast Milk and Plasma of Healthy Postpartum Women. Clinical Pharmacokinetics. 47(2). 103–109. 35 indexed citations
10.
Zhang, Lu, Jill Chappell, Celedon Gonzales, et al.. (2007). QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study. Journal of Cardiovascular Pharmacology. 49(3). 146–153. 52 indexed citations
11.
Derby, Michael A., Celedon Gonzales, Jill Chappell, et al.. (2005). QT interval analyses from a placebo and positive controlled study evaluating the electrophysiological effects of duloxetine at supratherapeutic doses. Clinical Pharmacology & Therapeutics. 77(2). P12–P12. 2 indexed citations
12.
Small, D. S., Corina Loghin, Ruth Lucas, et al.. (2005). Pharmacokinetic evaluation of combined duloxetine and fluvoxamine dosing in CYP2D6 poor metabolizers. Clinical Pharmacology & Therapeutics. 77(2). P37–P37. 7 indexed citations
13.
Chappell, Jill, Steven J. St. John, & Alan C. Spector. (1998). Amiloride Does not Alter NaCl Avoidance in Fischer-344 Rats. Chemical Senses. 23(2). 151–157. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth S. Duke Breakdown of academic impact, for papers by AF Cohen Breakdown of academic impact, for papers by Kwee Poo Yeo Breakdown of academic impact, for papers by C. Dubruc Breakdown of academic impact, for papers by Dwain Tolbert Breakdown of academic impact, for papers by Richard Bergstrom Breakdown of academic impact, for papers by Nevena Divac Breakdown of academic impact, for papers by Gudrun Hefner Breakdown of academic impact, for papers by Aleksandra Dragičević Breakdown of academic impact, for papers by Shobha Reddy
Rankless by CCL
2026